INJECT ApS: Financial statements 2014
CVR: 33867581
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
INJECT ApS (CVR 33867581) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK -10,802 and a net result of DKK -10,807 compared with DKK -14,364 the year before. Equity in the 2014 report amounted to DKK 577,483. The solvency ratio was 18.9%.
- Gross Profit
- DKK -10,802
- Profit/Loss
- DKK -10,807
- Equity
- DKK 577,483
- Total Assets
- DKK 3,061,608
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -11 t. | -11 t. | 577 t. | - |
| 2013 | - | -14 t. | -14 t. | 588 t. | - |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
INJECT ApS has published its annual report for 2013. Gross profit came to DKK -14,364, and the net result was DKK -14,364.
About INJECT ApS
INJECT ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2011. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Felix Hetting. The company is owned by MAFO ApS, Tina Hetting Holding I ApS and ASYRINGE LIMITED. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 0.